Looking to publish in Breast Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowBreast Cancer: Targets and Therapy is an international, peer reviewed, open access journal that publishes basic and translational studies as well as clinical trials on breast cancer. It encourages original and review articles on breast cancer treatment, including outcome studies that incorporate preventative and integrated treatment strategies to enhance survival and quality of life for cancer patients, and covers topics such as epidemiology, screening, biomarkers, metastasis, drug delivery systems, radiation, surgery, palliative care, health economics, and genetic and epigenetic mechanisms.
Looking to publish in Breast Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Breast Cancer Research accepts the following article types. Click on an article type to view submission instructions.
Letter To The Editor
Recent Publications
Physical activity and telomere length in early stage breast cancer survivors
Sheila N Garland, Brad Johnson, Christina Palmer, Rebecca M Speck, Michelle Donelson, Sharon X Xie, Angela DeMichele, Jun J Mao
Relationships between computer-extracted mammographic texture pattern features and
Gretchen L Gierach, Hui Li, Jennifer T Loud, Mark H Greene, Catherine K Chow, Li Lan, Sheila A Prindiville, Jennifer Eng-Wong, Peter W Soballe, Claudia Giambartolomei, Phuong L Mai, Claudia E Galbo, Kathryn Nichols, Kathleen A Calzone, Olufunmilayo I Olopade, Mitchell H Gail, Maryellen L Giger
Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study
Song Yao, Gary Zirpoli, Dana H Bovbjerg, Lina Jandorf, Chi-Chen Hong, Hua Zhao, Lara E Sucheston, Li Tang, Michelle Roberts, Gregory Ciupak, Warren Davis, Helena Hwang, Candace S Johnson, Donald L Trump, Susan E McCann, Foluso Ademuyiwa, Karen S Pawlish, Elisa V Bandera, Christine B Ambrosone
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Daphne SC Lee, Sook-Yee Yoon, Lai Meng Looi, Peter Kang, In Nee Kang, Kavitta Sivanandan, Hany Ariffin, Meow Keong Thong, Kin Fah Chin, Nur Aishah Mohd Taib, Cheng Har Yip, Soo Hwang Teo
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
Yi Fang Lee, Lance DAVID Miller, Xiu BIN Chan, Michael A Black, Brendan Pang, Chee WEE Ong, Manuel Salto-Tellez, Edison T Liu, Kartiki V Desai
Frequently asked questions
How long does it take to publish?
Offers Accelerated Publication.
Reformat to Breast Cancer Research using Livewrite PremiumIs a cover letter required?
A cover letter is required upon submission and must include at least three possible reviewers without conflicts of interest; academic email addresses are highly recommended.
Reformat to Breast Cancer Research using Livewrite PremiumWhat are the publication costs?
Hybrid journal. Article processing charges (APCs) vary by journal.
Reformat to Breast Cancer Research using Livewrite Premium